# SLE Digital Twin Living Requirements Specification (SLE-DT LRS)

## Revision Status
Integrated Literature Reviews
1. SLE DEG Bioinformatics Review.
2. AI, Biomarkers, and Precision Rheumatology Review.
3. Digital Twins and the Metaverse in Healthcare Review.
4. AI Autoimmune Research Trends (2025 Bibliometric Analysis).

---

## Document Purpose
This document is the authoritative living requirements specification for the SLE Digital Twin (SLE-DT) thesis project. Future literature reviews, datasets, biological discoveries, architectural decisions, and validation requirements shall be merged into this specification.

---

## Canonical Thesis Direction
### Selected MVP Architecture
Transcriptomics-First + Molecular-Endotype-Aware Healthcare Digital Twin.

### Scope Decision
The MVP shall focus exclusively on Systemic Lupus Erythematosus (SLE) rather than lupus broadly or lupus nephritis specifically.

### DT Classification
- Patient-specific healthcare Digital Twin.
- Immune-system Digital Twin.
- Research and discovery Digital Twin.
- Hypothesis-generation Digital Twin.
- Immune-tolerance-restoration Digital Twin.

Not intended as:
- Clinical decision-support software.
- Regulatory-grade medical device.
- Treatment recommendation engine.
- Metaverse platform.

### Research Objective Representation
The Digital Twin represents:
- Patient immune state.
- Disease-state deviation from health.
- Molecular endotypes.
- Candidate immune-restoration opportunities.

---

## Executive Thesis Objective
Develop an explainable Digital Twin capable of:
- Modeling patient-specific immune dysregulation.
- Identifying disease-driving genes and pathways.
- Discovering molecular endotypes.
- Simulating restoration of immune tolerance.
- Prioritizing candidate therapeutic targets.
- Generating testable biological hypotheses.

---

## MVP Requirements
### Included
- Public GEO transcriptomic datasets.
- Healthy control cohorts.
- Healthy reference twin.
- Patient-specific twin.
- Differential gene expression analysis.
- Pathway analysis.
- Protein-protein interaction analysis.
- Molecular endotype identification.
- Virtual perturbation engine.
- Explainable target ranking.
- Technical validation.
- Biological validation.

### Explicitly Out of Scope
- Wet-lab validation.
- Clinical deployment.
- Real-time monitoring.
- Wearables.
- EHR integration.
- Imaging integration.
- Multi-omics integration.
- Drug recommendation.

---

## Architecture Evolution Roadmap
### Phase 1 (Thesis MVP)
- Transcriptomics.
- Healthy controls.
- Endotype stratification.
- Healthy twin.
- Patient twin.
- Twin comparison.
- Target prioritization.

### Phase 2
- Proteomics.
- Cytokines.
- Serology.
- Composite biomarkers.
- Treatment-response prediction.

### Phase 3
- Longitudinal twins.
- EHR integration.
- Digital biomarkers.
- Wearables.
- Continuous recalibration.
- Drift monitoring.

### Phase 4
- Organ-specific twins.
- Multimodal twins.
- System-wide lupus twins.

---

## Scientific Foundation
### Immune Tolerance Restoration
The primary objective is restoration of immune homeostasis rather than disease prediction.

### Neutrophil Biology
Mandatory pathway categories:
- Neutrophil activation.
- Neutrophil-mediated immunity.
- Neutrophil degranulation.

### Interferon Biology
Mandatory pathway family:
- Type-I interferon signaling.

### Priority Hub Genes
- CCNB2
- CDCA8
- AURKB
- BUB1B
- RRM2
- BIRC5
- UBE2C

---

## Data Strategy
### Core Datasets
- GSE162828.
- GSE169080.

### Critical Data Requirement
Healthy-control cohorts shall be treated as a first-class requirement because robust disease-vs-health comparisons are essential for biomarker discovery, endotype identification, and Digital Twin construction.

### Additional Sources
- ImmPort.
- ArrayExpress.
- Additional GEO SLE datasets.

### Dataset Quality Requirements
Capture where available:
- Age.
- Sex.
- Ethnicity/ancestry.
- Disease subtype.
- Clinical metadata.

### Dataset Bias Documentation
Document:
- Population representation.
- Geographic representation.
- Language-source bias.
- Missing demographic information.

---

## Interdisciplinary Collaboration Requirements
The project should incorporate expertise from:
- Rheumatology.
- Immunology.
- Bioinformatics.
- Data science.
- Artificial intelligence.
- Healthcare informatics.

Future extensions may additionally involve:
- Nephrology.
- Neurology.
- Cardiovascular medicine.
- Clinical research.

---

## Molecular Endotype Layer
Purpose:
- Discover biologically meaningful SLE subgroups.

Signals:
- Gene-expression similarity.
- Interferon activity.
- Pathway activation.
- Immune-state signatures.

Outputs:
- Endotype definitions.
- Cluster descriptions.
- Endotype-specific disease drivers.
- Endotype-specific restoration opportunities.

---

## Biomarker Framework
### MVP Biomarkers
- DEGs.
- Pathway signatures.
- Hub genes.
- Endotype signatures.

### Future Biomarkers
- Proteomic biomarkers.
- Cytokine biomarkers.
- Serologic biomarkers.
- Imaging biomarkers.
- Digital biomarkers.

### Long-Term Principle
Composite biomarker models should replace single-marker approaches whenever data availability supports this evolution.

---

## Digital Twin Architecture Requirements
1. Data ingestion.
2. Quality control.
3. DEG engine.
4. Pathway engine.
5. Network engine.
6. Endotype engine.
7. Healthy twin generation.
8. Patient twin generation.
9. Twin comparison engine.
10. Perturbation engine.
11. Explainability engine.
12. Target ranking engine.
13. Validation engine.

### Architecture Principle
No universally optimal Digital Twin architecture exists. Architecture decisions must remain driven by the specific SLE research objective.

---

## Validation and Verification Framework
### Technical Validation
- Reproducibility.
- Stability.
- Sensitivity analysis.
- Cross-dataset consistency.

### Biological Validation
Recovery of:
- Neutrophil pathways.
- Interferon pathways.
- Published hub genes.
- Literature-supported biomarkers.

### Validation Principle
Validation and verification are first-class project requirements.

---

## Feedback Loop Requirements
Future architecture should support:
- Data refresh.
- Recalibration.
- Traceability.
- Performance evaluation.
- Drift monitoring.

---

## Security, Ethics, and Governance
### Privacy
- Public datasets only in MVP.
- No protected health information.

### Governance
- Explainable outputs.
- Transparent documentation.
- Bias review.

### Security
Future systems should support secure management of integrated healthcare data.

---

## Responsible AI Requirements
- TRIPOD+AI alignment.
- PROBAST+AI considerations.
- Fairness assessment.
- Population representation review.
- Generalizability assessment.
- Drift-monitoring roadmap.

---

## Open Research Questions
Remaining unanswered by reviewed literature:
1. Can deep learning outperform DEG-to-PPI workflows?
2. Which hub genes remain important under graph-learning models?
3. Can machine learning recover biologically meaningful genes filtered by traditional thresholds?
4. How accurately can transcriptomics alone predict therapeutic targets?
5. Are public longitudinal SLE cohorts available?
6. How should production Digital Twins implement drift monitoring?
7. Can subtype-specific twins outperform generalized SLE twins?
8. How should wearable-derived biomarkers be integrated?
9. Which public datasets contain both molecular and digital-health data?
10. What minimum biomarker set is necessary for a clinically useful lupus twin?
11. Has a fully customizable patient-specific SLE Digital Twin already been demonstrated?
12. Which healthcare Digital Twin category best aligns with lupus research goals?
13. Would an organ-specific lupus Digital Twin provide sufficient MVP value?
14. Should long-term architecture evolve toward system-wide or organ-specific twins?
15. Which lupus target organ would provide the highest-value future organ-level twin?
16. Are existing lupus organ-simulation platforms available?
17. Which biological, clinical, behavioral, and environmental variables are essential for a clinically meaningful Lupus-DT?

### Questions Resolved by Current Literature
- How can the scope be narrowed? → Focus on SLE, transcriptomics, molecular endotypes, immune-state modeling, and tolerance restoration.
- What should the Digital Twin represent? → Patient-specific immune state and disease-state deviation from health.

---

## Expected Thesis Contributions
- Explainable SLE Digital Twin architecture.
- Molecular-endotype-aware disease modeling.
- Immune-tolerance restoration framework.
- Neutrophil-centric target prioritization.
- Validation-oriented healthcare Digital Twin methodology.
- Reproducible research platform.
- Publishable biological hypotheses.

---

## References (IEEE)
[1] Y. Zhao et al., Identification of Biomarkers and Pathways in Systemic Lupus Erythematosus Through Integrated Bioinformatics Analysis, 2021.
[2] GSE162828, Gene Expression Omnibus.
[3] GSE169080, Gene Expression Omnibus.
[4] STRING Database.
[5] Cytoscape.
[6] M. E. Ritchie et al., limma.
[7] Artificial Intelligence, Biomarkers, and Precision Medicine in Autoimmune Inflammatory Rheumatic Diseases.
[8] Digital Twins and the Metaverse in Healthcare and Industry.
[9] Artificial Intelligence and Autoimmune Disease Research Trends (2025 Bibliometric Analysis).
